ArticleOpen forum infectious diseases2022
Global Emergence of Resistance to Fluconazole and Voriconazole in
Open access · goldAbstract read
In one paragraph
Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 48 citations in OpenAlex.
- Contemporary Trends in Candidemia: Mortality, Species, and Antifungal Resistance Across Three Periods (2017-2025) in Houston, Texas.Open forum infectious diseases · 2026Article
- Incidence of azole resistance among clinical isolates ofNew microbes and new infections · 2026Article
- Temporal Trends and Seasonality of Invasive Candidiasis During and After the COVID-19 Pandemic: An Interrupted Time Series Analysis in Colombia.Journal of fungi (Basel, Switzerland) · 2026Article
- Candidemia in Southern Poland (2017-2022): Multicenter Analysis of Species Distribution and Antifungal Susceptibility.Journal of fungi (Basel, Switzerland) · 2026Article
- Contribution of DNA Metabarcoding to the Environmental Fungal Assessments in Hospitals.Microbial ecology · 2025Article
- Article
- Clinical impact of fluconazole-resistantFuture microbiology · 2025Review
- The S862C amino acid change in CpMrr1 confers fluconazole resistance inJAC-antimicrobial resistance · 2025Article
- Risk factors and outcome for bloodstream infections due to fluconazole-resistant Candida parapsilosis: a 22-year single-center retrospective study.Antimicrobial resistance and infection control · 2025Article
- Characterization of COVID-19-Associated Candidemia Among Burn Patients.Journal of clinical laboratory analysis · 2025Article
- Resistance to Azoles inJournal of fungi (Basel, Switzerland) · 2025Article
- [Azole-resistantRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025Article
- Antimicrobial and antiparasitic potential of lupeol: antifungal effect on theJournal of medical microbiology · 2025Article
- The multidrug-resistantCurrent research in microbial sciences · 2025Review
- Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections.Nature medicine · 2024Article
- Clinical Characteristics of Candidemia Due toJournal of fungi (Basel, Switzerland) · 2024Article
- Increase in candidemia cases and emergence of fluconazole-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024Article
- Precise genome editing underlines the distinct contributions of mutations inAntimicrobial agents and chemotherapy · 2024Article
- Molecular and Epidemiological Investigation of Fluconazole-resistantOpen forum infectious diseases · 2024Article
- Epidemiological Assessment and Risk Factors for Mortality of Bloodstream Infections byJournal of fungi (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
36 authors at 12 institutions in 1 country.
Nuria Trevijano-ContadorMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III. Carretera Majadahonda-Pozuelo, Madrid, Spain.
Alba Torres-CanoMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III. Carretera Majadahonda-Pozuelo, Madrid, Spain.
Cristina Carballo-GonzálezMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III. Carretera Majadahonda-Pozuelo, Madrid, Spain.
Mireia Puig-AsensioDepartment of Infectious Diseases, Hospital Universitari de Bellvitge-Institut d´Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.ORCID https://orcid.org/0000-0002-0722-2218
María Teresa Martín-GómezDepartment of Microbiology, Vall D'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
Emilio Jiménez-MartínezDepartment of Infectious Diseases, Hospital Universitari de Bellvitge-Institut d´Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.ORCID https://orcid.org/0000-0003-2831-037X
Daniel RomeroDepartment of Microbiology, Vall D'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
Francesc Xavier NuvialsIntensive Care Unit, Vall D'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
Roberto Olmos-ArenasMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain.
María Clara Moretó-CastellsaguéMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain.
Lucía Fernández-DelgadoMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain.
Graciela Rodríguez-SevillaMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain.
María-Mercedes Aguilar-SánchezMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain.
Josefina Ayats-ArditeMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain.
Carmen Ardanuy-TisaireMicrobiology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain.
Isabel Sanchez-RomeroMicrobiology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
María Muñoz-AlgarraMicrobiology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Paloma Merino-AmadorMicrobiology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain.
Fernando González-RomoMicrobiology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain.
Gregoria Megías-LobónDepartment of Clinical Microbiology, Hospital Universitario de Burgos, Burgos, Castilla y León, Spain.
Jose Angel García-CamposDepartment of Clinical Microbiology, Hospital Universitario de Burgos, Burgos, Castilla y León, Spain.
María Ángeles Mantecón-VallejoDepartment of Clinical Microbiology, Hospital Universitario de Burgos, Burgos, Castilla y León, Spain.
Eva AlcocebaClinical Microbiology Department, Hospital Universitari Son Espases, Mallorca, Spain.
Pilar EscribanoClinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.ORCID https://orcid.org/0000-0001-6254-4570
Jesús GuineaInstituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
Maria Teresa Durán-ValleMicrobiology and Parasitology Department, Hospital Universitario de Móstoles, Madrid, Spain.
Arturo Manuel Fraile-TorresMicrobiology and Parasitology Department, Hospital Universitario de Móstoles, Madrid, Spain.
María Pía Roiz-MesonesMicrobiology Department, Marqués de Valdecilla Universitary Hospital and Instituto de Investigación Valdecilla (IDIVAL), Santander, Cantabria, Spain.
Isabel Lara-PlazaMicrobiology Department, Marqués de Valdecilla Universitary Hospital and Instituto de Investigación Valdecilla (IDIVAL), Santander, Cantabria, Spain.
Ana Pérez de AyalaMicrobiology Unit, Universitary Hospital 12 de Octubre, Madrid, Spain.
María Simón-SacristánMicrobiology and Parasitology Department, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain.
Ana Collazos-BlancoMicrobiology and Parasitology Department, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain.
Teresa Nebreda-MayoralMicrobiology and Immunology Unit, Universitary Clinic Hospital of Valladolid, Valladolid, Spain.
Gabriel March-RosellóMicrobiology and Immunology Unit, Universitary Clinic Hospital of Valladolid, Valladolid, Spain.
Laura Alcázar-FuoliMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III. Carretera Majadahonda-Pozuelo, Madrid, Spain.
Oscar ZaragozaMycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III. Carretera Majadahonda-Pozuelo, Madrid, Spain.
Bellvitge University Hospital · ESInstituto de Salud Carlos III · ESHospital Universitario de Burgos · ESUniversitat Autònoma de Barcelona · ESHospital Central de la Defensa Gómez Ulla · ESHospital Clínico Universitario de Valladolid · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario de Móstoles · ESHospital Universitario Puerta de Hierro Majadahonda · ESInstituto de Investigación Marqués de Valdecilla · ESUniversidad Complutense de Madrid · ESHospital Universitario Son Espases · ES
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: Yeast were identified by molecular biology, and antifungal susceptibility testing was performed using the European Committee on Antimicrobial Susceptibility Testing protocol. The Results: We examined the susceptibility profile of 1315 Conclusions: Our data suggest that concurrently with the coronavirus disease 2019 pandemic, a selection of fluconazole-resistant
Indexed as
antifungal resistanceCandida parapsilosisfluconazoleoutbreaksvoriconazole
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.